首页> 美国卫生研究院文献>International Journal of Surgery Case Reports >A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy
【2h】

A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy

机译:不进行全身辅助治疗的细胞减灭术和术中高温腹腔内化疗治疗卵巢癌合并腹膜转移性卵巢癌1例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHepatoid Carcinoma of the Ovary (HCO) is a rare subtype of ovarian cancers where malignant cells undergo hepatoid metamorphic changes and cytologically resemble hepatocytes. There are many case reports of HCO in the literature, and patients with these tumors are almost uniformly treated with palliative debulking and conventional adjuvant chemotherapy. To our knowledge, there is only one case report of HCO complicated by peritoneal dissemination that was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS plus HIPEC), followed by adjuvant chemotherapy.
机译:背景卵巢类肝癌(HCO)是一种罕见的卵巢癌亚型,其恶性细胞会经历肝样变质变化,并且在细胞学上类似于肝细胞。文献中有许多HCO的病例报道,患有这些肿瘤的患者几乎可以通过姑息性减灭术和常规辅助化疗进行统一治疗。据我们所知,只有1例HCO并发腹膜扩散的病例,通过细胞减灭术+腹膜热化学疗法(CRS + HIPEC)进行辅助化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号